(Q74310650)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9500717%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

title

Interferon alfa treatment of HCV RNA carriers with persistently normal transaminase levels: a pilot randomized controlled study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9500717%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9500717%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

author name string

R Morales

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9500717%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

G Spinzi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9500717%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

M Rumi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9500717%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

A Casiraghi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9500717%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

R Ceriani

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9500717%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

E Colombo

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9500717%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

M Fossati

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9500717%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

A Prada

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9500717%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

E Tavani

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9500717%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

G Minoli

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9500717%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

language of work or name

English

0 references

publication date

1 March 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9500717%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9500717%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9500717%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

853-856

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9500717%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9500717%20AND%20SRC:MED&resulttype=core&format=json

Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV.

10 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270330

7 January 2021

Normal aminotransferase concentrations in patients with antibodies to hepatitis C virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270330

7 January 2021

Volunteer blood donors with antibody to hepatitis C virus: clinical, biochemical, virologic, and histologic features. The Hepatitis C Study Group

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270330

7 January 2021

Chronic hepatitis in United Kingdom blood donors infected with hepatitis C virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270330

7 January 2021

Chronic hepatitis C in patients with normal or near normal alanine aminotransferase levels: the role of interferon alpha 2b therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270330

7 January 2021

Therapy of hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270330

7 January 2021

Clinical and histologic predictors of response to interferon-alpha in patients with chronic hepatitis C viral infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270330

7 January 2021

Hepatitis C virus RNA and antibody response in the clinical course of acute hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270330

7 January 2021

Typing of hepatitis C virus isolates by DNA enzyme immunoassay

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270330

7 January 2021

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270330

7 January 2021

Histological grading and staging of chronic hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270330

7 January 2021

Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270330

7 January 2021

T-cell response to structural and nonstructural hepatitis C virus antigens in persistent and self-limited hepatitis C virus infections

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270330

7 January 2021

A prospective, randomized trial comparing lymphoblastoid to recombinant interferon alfa 2a as therapy for chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270330

7 January 2021

Hepatitis C virus type 1b (II) infection in France and Italy. Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270330

7 January 2021

Lack of benefit of escalating dosage of interferon alfa in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270330

7 January 2021

The interferons. Mechanisms of action and clinical applications

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270330

7 January 2021

Therapy of hepatitis C: patients with normal aminotransferase levels

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270330

7 January 2021

Identifiers

DOI

10.1002/HEP.510270330

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9500717%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference